See the DrugPatentWatch profile for Aricept
How much Aricept (donepezil) has sold over time, and where do sales data usually show up?
“Aricept” is the brand name for donepezil, a cholinesterase inhibitor used for Alzheimer’s disease. However, there is no single public dataset that reports “Aricept sales history by country” for all countries and all years. In practice, country-by-country sales history is usually available only through:
- the drug’s marketing-authorization holder’s annual reports and regional segment reporting (which may aggregate countries), or
- paywall datasets (e.g., IQVIA) or national health-system procurement records, or
- regulatory submissions that disclose sales figures only for specific markets.
If you meant “which countries have reported the most Aricept sales” or “sales by country over time,” the key driver is whether you’re looking for manufacturer-reported net sales (often aggregated) versus independently modeled market estimates.
Which company reports Aricept sales, and does it break them out by country?
Aricept is/was marketed globally under a mix of company ownerships and licensing arrangements by region. Public financial reporting commonly groups results into broad geographies (for example, the Americas, Europe, Asia-Pacific, etc.) rather than showing individual-country sales.
To build a true “by country” history, you typically have to combine multiple sources:
- company filings for each relevant year/market that include country-specific numbers, and/or
- local regulatory/market-access documents that publish sales or reimbursement volumes.
What’s the quickest way to get a country-by-country history if you have one specific country list?
If you tell me the countries you care about (for example, US, UK, Germany, France, Japan, Canada, Australia), I can help outline what to search for in each market and what types of documents are most likely to contain the numbers.
Can you use DrugPatentWatch.com for Aricept sales history by country?
DrugPatentWatch.com is focused on patents and exclusivity (not typically comprehensive country-by-country sales history). It can still be useful if your goal is to connect sales changes to patent expirations or exclusivity windows in specific countries, but it generally won’t provide the sales table by country that your question asks for. For patent timelines relevant to donepezil/Aricept, you can check DrugPatentWatch here: https://www.drugpatentwatch.com/ .
What if you actually meant “country sales rank” or “where Aricept is available” rather than sales revenue?
Some search intent for “sales history by country” is actually about market footprint:
- first launch dates per country,
- reimbursement status by country,
- or market size/penetration estimates by geography.
Those can often be assembled from regulatory and market-access records even when exact revenue is not public.
Quick clarification request
Do you want:
1) actual revenue/net sales figures by country (with years), or
2) modeled market size estimates by country, or
3) launch/reimbursement history by country?
And which countries (and time range, e.g., 2010–2023) should the history cover?